1. [Thyroid papillary microcarcinoma. Salah Azaiz Institute experience].
- Author
-
Oueslati Z, Aloui M, Gritli S, Touati S, el-May A, Gamoudi A, Ben-Slimene F, and Ladgham A
- Subjects
- Adolescent, Adult, Aged, Bone Neoplasms radiotherapy, Bone Neoplasms secondary, Child, Diagnosis, Differential, Female, Humans, Incidence, Iodine Radioisotopes therapeutic use, Male, Middle Aged, Prognosis, Survival Analysis, Tunisia epidemiology, Carcinoma, Papillary diagnosis, Carcinoma, Papillary pathology, Carcinoma, Papillary radiotherapy, Thyroid Neoplasms diagnosis, Thyroid Neoplasms pathology, Thyroid Neoplasms radiotherapy
- Abstract
The incidence of thyroid papillary microcarcinoma appears to be increasing and therapeutic modalities remain controversial. This retrospective study concerns 25 cases, from 1978 to 1999. The circumstances of diagnosis were: a cervicotomy for thyroid nodule (88% of cases), cervical node metastases (8%), and osseous metastases (4%). The sensitivity of ultrasounds was 22.2%, that of scintigraphy was 9.1% and that of extemporaneous histological examination was 18.2%. Multifocality was found in 16% of cases and bilaterality in 16.6%. Treatment modalities were guided by histological examination. Adjunctive radioiodine ablation was used for 20% of the patients. The treatment of the osseous metastases was completed with external irradiation. The average follow up was 4.8 years (4 months to 19 years), with a rate of survival without disease of 100%.
- Published
- 2002